We present a remote, multimodal video framework analyzing 829 participants, including 158 <i>LRRK2</i> carriers (36 with manifest PD, 122 non-manifest), to address two key challenges: detecting high-risk carriers prior to clinical diagnosis and monitoring early disease-related change. This evidence concerns the gene LRRK2 and Parkinson disease.